The current ESGO/ESTRO/ESP pointers to the management of sufferers with EC include the molecular classification to the definition of possibility teams 52. ) attained even now an unbiased prognostic worth. as being a conclusion, that lack of CK5/six expression is Recurrent in endometrioid-sort ECs and is connected to intense tumor behavior and decr